Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance
Authors:
- 23 May 2023
- journal article
- research article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 22 (8) , 103362
Abstract
No abstract availableKeywords
Funding Information
- Kommission für Technologie und Innovation
This publication has 180 references indexed in Scilit:
- Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical TrialsOphthalmology, 2013
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitisArthritis & Rheumatism, 2011
- EULAR recommendations for the management of primary small and medium vessel vasculitisAnnals of the Rheumatic Diseases, 2009
- A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effectsAnnals of the Rheumatic Diseases, 2008
- Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open‐label study of twenty‐two patientsArthritis & Rheumatism, 2007
- The first case of a patient with neutropenia and giant-cell arteritis treated with rituximabClinical Rheumatology, 2007
- EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitisAnnals of the Rheumatic Diseases, 2007
- Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patientsArthritis Care & Research, 2007
- Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritisAnnals of the Rheumatic Diseases, 2005
- Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritisArthritis & Rheumatism, 2004